Advisory Committee Tells FDA Clinical Genetic Tests Should Only Be Provided Through Docs, Not DTC

On the first day of a two-day meeting, the majority of advisory committee panelists asserted that without the involvement of a medical professional, patients may misunderstand or fail to recognize when a genetic test result is meaningful for their health.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.